BTX 1204

· Botanix Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BTX 1204, covering 2022-09-27 to 2022-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis [Phase 2]